CAR-T therapy targeting TM4SF1 in aggressive bladder cancer (HV) histologic variant , offering hope for treatment-resistant ...

Scientists found a way to identify and possibly treat a mysterious type of bladder cancer that affects up to 1 in 4 cases.

Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

DelveInsight's, “Bladder Cancer Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 100+ ...

Despite a recent rebuff from an FDA advisory committee, the first treatment for a specific and underserved cohort of U.S. | ...

With topical estrogen, the vaginal flora returns back to the premenopausal stage with less E. coli -- a common cause of ...

“Pelvic floor therapy is like physical therapy to strengthen all the muscles and tissues in your pelvis that can become weak ...

In the neoadjuvant and adjuvant phases of arm C, pembrolizumab will be administered on day 1 and enfortumab vedotin will be administered on days 1 and 8 of each cycle. Enrollment is complete for arm A ...

Bladder cancer can be a silent killer, often presenting few symptoms in its early stages. Learn about the disease, its early symptoms, and more.

In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.